Letting post-marketing bridge the evidence gap: the case of orphan drugs

MeSH terms

• Adrenal Cortex Neoplasms / drug therapy*
• Adrenocortical Carcinoma / drug therapy*
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents, Hormonal / therapeutic use
• Barrett Esophagus / drug therapy
• Cladribine / therapeutic use
• Dihematoporphyrin Ether / therapeutic use
• Ductus Arteriosus, Patent / drug therapy
• Hepatolenticular Degeneration / drug therapy
• Humans
• Ibuprofen / therapeutic use
• Leukemia, Hairy Cell / drug therapy
• Mitotane / therapeutic use
• Orphan Drug Production*
• Platelet Aggregation Inhibitors / therapeutic use
• Product Surveillance, Postmarketing*
• Quinazolines / therapeutic use
• Thrombocythemia, Essential / drug therapy
• Zinc Acetate / therapeutic use